EMERGING NEW THERAPIES

Sponsored By 

Concurrent Speaker(s)

• 

  Ganna Bilousova, PhD (she/her/hers)

  Dermatology
  University of Colorado Anschutz Medical Campus, USA
• 

  Ludovic Vallier, PhD

  Berlin Institute of Health at Charite, Germany

Presenting Author(s)

• 

  Jacqueline Bliley

  Department of Biomedical Engineering
  Carnegie Mellon University, USA
• 

  Tatsuma Kondo, MD (he/him/his)

  Department of Neurosurgery
  Nagoya University, Japan
• 

  Shulin Li, PhD, PhD

  Pediatrics - Research
  The University of Texas MD Anderson Cancer Center, USA
• 

  Holly Voges, PhD

  Stem Cell Biology
  Murdoch Childrens Research Institute, Australia

Therapies spanning a range of modalities, including in-situ / direct reprogramming, direct gene editing, and gene-edited cell therapies will be highlighted in this session.

Presentations:

• A PERSONALIZED iPSC-BASED THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA DELIVERED VIA CELL SUSPENSION: PRE-CLINICAL DEVELOPMENT
  

  Concurrent Speaker: Ganna Bilousova, PhD (she/her/hers) – University of Colorado Anschutz Medical Campus
• TRANSPLANTATION OF ACTH-SECRETING HUMAN PLURIPOTENT STEM CELL (HPSC)-DERIVED PITUITARY CELLS
  

  Presenting Author: Tatsuma Kondo, MD (he/him/his) – Nagoya University
• BIOENGINEERING AND IN VIVO ASSESSMENT OF 3D BIOPRINTED HUMAN CARDIAC CONDUITS
  

  Presenting Author: Jacqueline Bliley – Carnegie Mellon University
• ATTIL12-T CELL THERAPY FOR SIMULTANEOUSLY DISRUPTING STROMA/TUMORS AND INDUCTION OF ENDOGENOUS TCR-T CELLS
  

  Presenting Author: Shulin Li, PhD, PhD – The University of Texas MD Anderson Cancer Center
• BIOENGINEERING HUMAN HEART VALVE TISSUE FOR CELLULAR REPAIR USING HUMAN PLURIPOTENT STEM CELLS
  

  Presenting Author: Holly K. Voges, PhD – Murdoch Childrens Research Institute
• CELL BASED THERAPY AGAINST LIVER DISEASES, WHAT'S NEW?
  

  Concurrent Speaker: Ludovic Vallier, PhD – Berlin Institute of Health at Charite